Medicine and Dentistry
Cervical Cancer
100%
Neoplasm
91%
Radiation Therapy
80%
Positron Emission Tomography
52%
Carcinoma
51%
Pelvis
51%
Brachytherapy
43%
Disease
36%
Chemotherapy
30%
Fluorodeoxyglucose
26%
Recurrent Disease
26%
Cervix
26%
Uterine Cervix
25%
Polyethylene Terephthalate
23%
Overall Survival
22%
Fluorodeoxyglucose F 18
22%
Uterine Cervix Carcinoma
21%
Lymph Node
20%
Treatment Planning
20%
Positron Emission Tomography-Computed Tomography
19%
Intensity Modulated Radiation Therapy
18%
Uterine Cancer
16%
Prognostic Factor
15%
Chemoradiotherapy
14%
Oncology
13%
Magnetic Resonance Imaging
13%
Malignant Neoplasm
13%
Disease Free Survival
12%
Progression Free Survival
12%
Drug Megadose
12%
Computer Assisted Tomography
12%
Paraaortic Lymph Node
12%
Cancer
11%
External Beam Radiotherapy
11%
Distant Metastasis
11%
Lymph Node Metastasis
10%
Implant
10%
Endometrium Carcinoma
9%
Pelvic Radiotherapy
9%
Clinical Stage
9%
Radiation Oncology
9%
Metabolism
9%
Metastatic Carcinoma
8%
High-Dose-Rate Brachytherapy
8%
Multivariate Analysis
7%
Radical Hysterectomy
7%
Glucose
7%
Standardized Uptake Value
7%
Bladder
7%
Cisplatin
7%
Keyphrases
Cervical Cancer
98%
Cervical Carcinoma
60%
Tumor
52%
Irradiation
52%
Radiation Therapy
34%
Brachytherapy
34%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
33%
Positron Emission Tomography
32%
Radiotherapy
25%
Overall Survival
22%
Chemotherapy
20%
Prognostic Factors
18%
Progression-free Survival
16%
Distant Metastasis
16%
Disease-free Survival
15%
Positron Emission Tomography-computed Tomography (PET-CT)
15%
Pelvis
14%
Intracavitary
14%
Intensity-modulated Radiation Therapy
14%
Stage IB
14%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
13%
Concurrent Chemotherapy
13%
Radiation Therapy Oncology Group
13%
Radiation Dose
12%
Para-aortic Lymph Node
11%
Endometrial Cancer
11%
Invasive Cervical Cancer
11%
High Dose
11%
HDR Brachytherapy
11%
Tumor Volume
10%
Cervical Cancer Patients
10%
Stage IA2
10%
Phase II Study
10%
Pelvic Lymph Nodes
9%
Locally Advanced Cervical Cancer
9%
Radiation Oncology
9%
Multivariate Analysis
9%
Tumor Size
9%
Recurrent Disease
9%
External Irradiation
9%
Radiotherapy Alone
9%
Cisplatin
8%
Carcinoma
8%
Treatment Planning
8%
Magnetic Resonance Imaging
8%
Local Control
8%
Gynecologic Malignancies
8%
Fluorodeoxyglucose
8%
Endometrial Carcinoma
8%
Fluorodeoxyglucose Uptake
8%